Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
To investigate the influence of genetic factors on the curative effect , to find the
relationships between genetic variants and the response of Methotrexate to treatment of
Psoriasis Vulgaris.